The developmental neurotoxicology of chemicals disrupting thyroid hormone signaling

Human Developmental Neurotoxicology

Volumn , Issue , 2006, Pages 447-461

  Zoeller, R Thomas ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37549063917     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (140)

1. Kilby MD. Thyroid hormones and fetal brain development. Clin Endocrinol (Oxf) 2003; 59:280-281.
2. Bernal J, Guadano-Ferraz A, Morte B. Perspectives in the study of thyroid hormone action on brain development and function. Thyroid 2003; 13:1005-1012.
3. Smith JW, Evans AT, Costall B, Smythe JW. Thyroid hormones, brain function and cognition: a brief review. Neurosci Biobehav Rev 2002; 26:45-60.
4. Bernal J. Action of thyroid hormone in brain. J Endocrinol Invest 2002; 25:268-288.
5. Delange FM. Endemic cretinism. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams and Wilkins, 2000:743-754.
6. Darbra S, Garau A, Balada F, Sala J, Marti-Carbonell MA. Perinatal hypothyroidism effects on neuromotor competence, novelty-directed exploratory and anxiety-related behaviour and learning in rats. Behav Brain Res 2003; 143:209-215.
7. Zoeller RT, Dowling ALS, Herzig CTA, Iannacone EA, Gauger KJ, Bansal R. Thyroid hormone, brain development, and the environment. Environ Health Perspect 2002; 110:355-361.
8. Brucker-Davis F. Effects of environmental synthetic chemicals on thyroid function. Thyroid 1998; 8:827-856.
9. Gaitan E, ed. Environmental Goitrogenesis. Boca Raton, FL: CRC Press, 1989.
10. Strawson J, Zhao Q, Dourson M. Reference dose for perchlorate based on thyroid hormone change in pregnant women as the critical effect. Regul Toxicol Pharmacol 2004; 39:44-65.
11. Wolff J. Perchlorate and the thyroid gland. Phamacol Rev 1998; 50:89-105.
12. Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87:1068-1072.
13. Dunn JT, Dunn AD. Thyroglobulin: chemistry, biosynthesis, and proteolysis. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott, Williams and Wilkins, 2000:91-104.
14. Taurog A. Hormone synthesis: thyroid iodine metabolism. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams and Wilkins, 2000:61-85.
15. Herzog V. Transcytosis in thyroid follicle cells. J Cell Biol 1983; 97:607.
16. Spencer CA. Thyroglobulin. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia: Lippincott Williams and Wilkins, 2000:402-113.
17. Sellitti DF, Suzuki K, Doi SQ, et al. Thyroglobulin increases cell proliferation and suppresses Pax-8 in mesangial cells. Biochem Biophys Res Commun 2001; 285:795-799.
18. Wondisford FE, Magner JA, Weintraub BD. Thyrotropin. In: Braverman LE, Utiger RD, eds. The Thyroid: A Fundamental and Clinical Text. 7th ed. Philadelphia: Lippincott-Raven, 1996:190-206.
19. Rapoport B, Spaulding SW. Mechanism of action of thyrotropin and other thyroid growth factors. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Philadelphia: Lippincott-Raven, 1986:207-219.
20. Koller KJ, Wolff RS, Warden MK, Zoeller RT. Thyroid hormones regulate levels of thyrotropin-releasing hormone mRNA in the paraventricular nucleus. Proc Natl Acad Sci USA 1987; 84:7329-7333.
21. Segersen TP, Kauer J, Wolfe HC, et al. Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science 1987; 84:78-80.
22. Rondeel JMM, deGreef WJ, van der Schoot P, Karels B, Klootwijk W, Visser TJ. Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood. Endocrinology 1988; 123:523-527.
23. Lechan RM, Qi Y, Jackson IMD, Mahdavi V. Identification of thyroid hormone receptor isoforms in thyrotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Endocrinology 1994; 135:92-100.
24. Hodin RA, Lazar MA, Wintman BI, Darling DS, Chin WW. Identification of a thyroid hormone receptor that is pituitary-specific. Science 1989; 244:76-79.
25. Hodin RA, Lazar MA, Chin WW. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J Clin Invest 1990; 85:101-105.
26. Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocrine Rev 1993; 14:348-399.
27. Safer JD, O'Connor MG, Colan SD, Srinivasan S, Tollin SR, Wondisford FE. The thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to thyroid hormone. J Clin Endocrinol Metab 1999; 84:3099-3109.
28. Burmeister LA, Pachucki J, St Germain DL. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 1997; 138:5231-5237.
29. St Germain DL, Galton VA. The deiodinase family of selenoproteins. Thyroid 1997; 7:655-668.
30. Kohrle J. Local activation and inactivation of thyroid hormones: the deiodinase family. Mol Cell Endocrinol 1999; 151:103-119.
31. Kester MHA, Martinez de Mena R, Obregon MJ, et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 2004; 89:3117-3218.
32. Chatterjee VK, Tata JR. Thyroid hormone receptors and their role in development. Cancer Surv 1992; 14:147-167.
33. Whitfield GK, Jurutka PW, Haussler CA, Haussler MR. Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function. J Cell Biochem 1999; 33:110-122.
34. O'Shea PJ, Williams GR. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol 2002; 175:553-570.
35. Wondisford FE. Thyroid hormone action: insight from transgenic mouse models. J Investig Med 2003; 51:215-220.
36. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988; 240:889-895.
37. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 1993; 14:184-193.
38. Sap J, Munoz A, Damm K, et al. The c-erbA protein is a high affinity receptor for thyroid hormone. Nature 1986; 324:635-640.
39. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. The c-erbA gene encodes a thyroid hormone receptor. Nature 1986; 324:641-646.
40. Forrest D, Reh TA, Rusch A. Neurodevelopmental control by thyroid hormone receptors. Curr Opin Neurobiol 2002; 12:49-56.
41. Flamant F, Samarut J. Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab 2003; 14:85-90.
42. Chassande O, Fraichard A, Gauthier K, et al. Identification of transcripts initiated from an internal promoter in the c-erbAa locus that encode inhibitors of retinoic acid receptor-a and triiodothyronine receptor activities. Mol Endocrinol 1997; 11:1278-1290.
43. Williams GR. Cloning and characterization of two novel thyroid hormone receptor b isoforms. Mol Cell Biol 2000; 20:8329-8342.
44. Bradley DJ, Towle HC, Young WS. Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta-2 subtype, in the developing mammalian nervous system. J Neurosci 1992; 12:2288-2302.
45. Leonard JL, Farwell AP, Yen PM, Chin WW, Stula M. Differential expression of thyroid hormone receptor isoforms in neurons and astroglial cells. Endocrinol 1994; 135:548-555.
46. Fisher D, Dussault J, Sack J, Chopra I. Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep, rat. Rec Progr Horm Res 1977; 33:59-107.
47. Lazar MA. Thyroid hormone receptors: Update 1994. Endocr Rev Monogr 1994; 3:280-283.
48. Forrest D, Erway LC, Ng L, Altschuler R, Curran T. Thyroid hormone receptor beta is essential for development of auditory function. Nature Genet 1996; 13:354-357.
49. Forrest D, Hanebuth E, Smeyne RJ, et al. Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor ß: evidence for tissue-specific modulation of receptor function. EMBO J 1996; 15:3006-3015.
50. Gauthier K, Chassande O, Plateroti M, et al. Different functions for the thyroid hormone receptors TRalpha and TRbeta in the control of thyroid hormone production and post-natal development. EMBO J 1999; 18:623-631.
51. McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002; 108:465-474.
52. Morte B, Manzano J, Scanlan T, Vennstrom B, Bernal J. Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc Natl Acad Sci USA 2002; 99:3985-3989.
53. Gothe S, Wang Z, Ng L, et al. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 1999; 13:1329-1341.
54. Hashimoto K, Curty FH, Borges PP, et al. An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci USA 2001; 98:3998-4003.
55. Guadano-Ferraz A, Benavides-Piccione R, Venero C, et al. Lack of thyroid hormone receptor alpha1 is associated with selective alterations in behavior and hippocampal circuits. Mol Psychiatry 2003; 8:30-38.
56. Manzano J, Morte B, Scanlan TS, Bernal J. Differential effects of triiodothyronine and the thyroid hormone receptor beta-specific agonist GC-1 on thyroid hormone target genes in the brain. Endocrinology 2003; 144:5480-5487.
57. Morte B, Manzano J, Scanlan TS, Vennstrom B, Bernal J. Aberrant maturation of astrocytes in thyroid hormone receptor 1 knock out mice reveals an interplay between thyroid hormone receptor isoforms. Endocrinology 2004; 145:1386-1391.
58. Nicholson JL, Altman J. The effects of early hypo- and hyperthyroidism on the development of rat cerebellar cortex. I. Cell proliferation and differentiation. Brain Res 1972; 44:13-23.
59. Xiao Q, Nikodem VM. Apoptosis in the developing cerebellum of the thyroid hormone deficient rat. Front Biosci 1998; 3:A52-A57.
60. Moriyama K, Tagami T, Akamizu T, et al. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 2002; 87:5185-5190.
61. Kitamura S, Jinno N, Ohta S, Kuroki H, Fujimoto N. Thyroid hormonal activity of the flame retardants tetrabromobisphenol A and tetrachlorobisphenol A. Biochem Biophys Res Commun 2002; 293:554-559.
62. Cranefield P, Federn W. Paracelsus on Goiter and Cretinism: A Translation and Discussion of "De Struma Vulgo Der Kropf. Bull Hist Med 1963; 37:463-471.
63. Merke F. The history of endemic goitre and cretinism in the thirteenth to fifteenth centuries. Proc R Soc Med 1960; 53:995-1002.
64. DeLong GR, Ma T, Cao XY, et al. The neuromotor deficit in endemic cretinism. In: Stanbury JB, ed. The Damaged Brain of Iodine Deficiency. New York: Cognizant Communications, 1994:9-17.
65. Chan S, Rovet J. Thyroid hormones in the fetal central nervous system development. Fetal Mater Med Rev 2003; 14:177-208.
66. Brown AW, Bronstein IP, Kraines R. Hypothyroidism and cretinism in childhood. VI. Influence of thyroid therapy on mental growth. Amer J Dis Child 1939; 57:517-523.
67. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341:549-555.
68. Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999; 50:149-155.
69. Smit BJ, Kok JH, Vulsma T, Briet JM, Boer K, Wiersinga WM. Neurologic development of the newborn and young child in relation to maternal thyroid function. Acta Paediatr 2000; 89:291-295.
70. Glinoer D. Potential consequences of maternal hypothyroidism on the offspring: evidence and implications. Horm Res 2001; 55:109-114.
71. Calvo RM, Jauniaux E, Gulbis B, et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 2002; 87:1768-1777.
72. Pacaud D, Huot C, Gattereau A, et al. Outcome in three siblings with antibody-mediated transient congenital hypothyroidism. J Pediatr 1995; 127:275-277.
73. Matsuura N, Konishi J. Transient hypothyroidism in infants born to mothers with chronic thyroiditis-a nationwide study of twenty-three cases. The transient hypothyroidism study group. Endocrinol Jpn 1990; 37:369-379.
74. Rovet J. Congenital hypothyroidism: long-term outcome. Thyroid 1999; 9:741-748.
75. Heyerdahl S, Oerbeck B. Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid 2003; 13:1029-1038.
76. Oerbeck B, Sundet K, Kase BF, Heyerdahl S. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 2003; 112:923-930.
77. Friedhoff AJ, Miller JC, Armour M, Schweitzer JW, Mohan S. Role of maternal biochemistry in fetal brain development: effect of maternal thyroidectomy on behaviour and biogenic amine metabolism in rat progeny. Int J NeuropsychoPharmacol 2000; 3:89-97.
78. Sinha AK, Pickard MR, Kim KD, et al. Perturbation of thyroid hormone homeostasis in the adult and brain function. Acta Med Austriaca 1994; 21:35-43.
79. Sinha AK, Pickard MR, Hubank MJ, et al. Maternal hypothyroxinemia and brain development: II. Biochemical, metabolic and behavioural correlates. Acta Med Austriaca 1992; 19:49-54.
80. Hendrich CE, Jackson WJ, Porterfield SP. Behavioral testing of progenies of Tx (hypothyroid) and growth hormone- treated Tx rats: an animal model for mental retardation. Neuroendocrinology 1984; 38:429-437.
81. Eayrs JE, Taylor SH. The effect of thyroid deficiency induced by methyl thiouracil on the maturation of the central nervous system. J Anat 1951; 85:350-358.
82. Eayrs JT, Horne G. The development of the cerebral cortex in hypothyroid and starved rats. Anat Rec 1955; 121:53-61.
83. Eayrs JT. The cerebral cortex of normal and hypothyroid rats. Acta Anat 1955; 25:160-183.
84. Gravel C, Hawkes R. Maturation of the corpus callosum of the rat: I. Influence of thyroid hormones on the topography of callosal projections. J Comp Neurol 1990; 291:128-146.
85. Gravel C, Sasseville R, Hawkes R. Maturation of the corpus callosum of the rat: II. Influence of thyroid hormones on the number and maturation of axons. J Comp Neurol 1990; 291:147-161.
86. Berbel P, Guadano-Ferraz A, Angulo A, Ramon Cerezo J. Role of thyroid hormones in the maturation of interhemispheric connections in rats. Behav Brain Res 1994; 64:9-14.
87. Berbel P, Guadano-Ferraz A, Martinez M, Quiles JA, Balboa R, Innocenti GM. Organization of auditory callosal connections in hypothyroid adultrats. Eur J Neurosci. 1993; 5:1465-1478.
88. Berbel P, Marco P, Cerezo JR, DeFelipe J. Distribution of parvalbumin immunoreactivity in the neocortex of hypothyroid adult rats. Neurosci Lett 1996; 204:65-68.
89. Berbel P, Auso E, Garcia-Velasco JV, Molina ML, Camacho M. Role of thyroid hormones in the maturation and organisation of rat barrel cortex. Neuroscience 2001; 107:383-394.
90. Lavado-Autric R, Auso E, Garcia-Velasco JV, et al. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest 2003; 111:1073-1082.
91. Auso E, Lavado-Autric R, Cuevas E, Escobar Del Rey F, Morreale De Escobar G, Berbel P. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004; 145:4037-4047.
92. Howdeshell KL. A model of the development of the brain as a construct of the thyroid system. Environ Health Perspect 2002; 110:337-348.
93. Chana A, Concejero MA, de Frutos M, Gonzalez MJ, Herradon B. Computational studies on biphenyl derivatives. Analysis of the conformational mobility, molecular electrostatic potential, and dipole moment of chlorinated biphenyl: searching for the rationalization of the selective toxicity of polychlorinated biphenyls (PCBs). Chem Res Toxicol 2002; 15:1514-1526.
94. Breivik K, Sweetman A, Pacyna JM, Jones KC. Towards a global historical emission inventory for selected PCB congeners-a mass balance approach. 2. Emissions. Sci Total Environ 2002; 290:199-224.
95. Sjodin A, Jones RS, Focant JF, et al. Retrospective time-trend study of polybrominated diphenyl ether and polybrominated and polychlorinated biphenyl levels in human serum from the United States. Environ Health Perspect 2004; 112:654-658.
96. Huisman M, Koopman-Esseboom C, Lanting CI, et al. Neurological condition in 18-month-old children perinatally exposed to polychlorinated biphenyls and dioxins. Early Hum Dev 1995; 43:165-176.
97. Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horwitz KB. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domainbinding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol 1997; 11:693-705.
98. Osius N, Karmaus W, Kruse H, Witten J. Exposure to polychlorinated biphenyls and levels of thyroid hormones in children. Environ Health Perspect 1999; 107:843-849.
99. Korrick SA, Altshul L. High breast milk levels of polychlorinated biphenyls (PCBs) among four women living adjacent to a PCB-contaminated waste site. Environ Health Perspect 1998; 106:513-518.
100. Ayotte P, Muckle G, Jacobson JL, Jacobson SW, Dewailly E. Assessment of pre- and postnatal exposure to polychlorinated biphenyls: lessons from the Inuit cohort study. Environ Health Perspect 2003; 111:1253-1258.
101. Walkowiak J, Wiener JA, Fastabend A, et al. Environmental exposure to polychlorinated biphenyls and quality of the home environment: effects on psychodevelopment in early childhood. Lancet 2001; 358:1602-1607.
102. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia. J Clin Endocrinol Metab 2000; 85:3975-3987.
103. Porterfield SP, Hendry LB. Impact of PCBs on thyroid hormone directed brain development. Toxicol Ind Health 1998; 14:103-120.
104. Porterfield SP. Thyroidal dysfunction and environmental chemicals-potential impact on brain development. Environ Health Perspect 2000; 108:433-438.
105. McKinney JD, Waller CL. Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents. J Toxicol Env Hlth-Part B 1998; 1:27-58.
106. Koopman-Esseboom C, Morse DC, Weisglas-Kuperus N, et al. Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants. Pediatr Res 1994; 36:468-473.
107. Schantz SL, Widholm JJ, Rice DC. Effects of PCB exposure on neuropsychological function in children. Environ Health Perspect 2003; 111:357-376.
108. Sala M, Sunyer J, Herrero C, To-Figueras J, Grimalt J. Association between serum concentrations of hexachlorobenzene and polychlorobiphenyls with thyroid hormone and liver enzymes in a sample of the general population. Occup Environ Med 2001; 58:172-177.
109. Longnecker MP, Gladen BC, Patterson DG, Jr, Rogan WJ. Polychlorinated biphenyl (PCB) exposure in relation to thyroid hormone levels in neonates. Epidemiology 2000; 11:249-254.
110. Hagmar L, Rylander L, Dyremark E, Klasson-Wehler E, Erfurth EM. Plasma concentrations of persistent organochlorines in relation to thyrotropin and thyroid hormone levels in women. Int Arch Occup Environ Health 2001; 74:184-188.
111. Steuerwald U, Weihe P, Jorgensen PJ, et al. Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. J Pediatr 2000; 136:599-605.
112. Bastomsky CH, Murthy PVN, Banovac K. Alterations in thyroxine metabolism produced by cutaneous application of microscope immersion oil: effects due to polychlorinated biphenyls. Endocrinol 1976; 98:1309-1314.
113. Bastomsky CH. Effects of a polychlorinated biphenyl mixture (Aroclor 1254) and DDT on biliary thyroxine excretion in rats. Endocrinology 1974; 95:1150-1155.
114. Brouwer A, Morse DC, Lans MC, et al. Interactions of persistent environmental organohalides with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol Ind Health 1998; 14:59-84.
115. Goldey ES, Kehn LS, Rehnberg GL, Crofton KM. Effects of developmental hypothyroidism on auditory and motor function in the rat. Toxicol Appl Pharmacol 1995; 135:67-76.
116. Goldey ES, Kehn LS, Lau C, Rehnberg GL, Crofton KM. Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Toxicol Appl Pharmacol 1995; 135:77-88.
117. Crofton KM, Ding D, Padich R, Taylor M, Henderson D. Hearing loss following exposure during development to polychlorinated biphenyls: a cochlear site of action. Hear Res 2000; 144:196-204.
118. Crofton KM, Kodavanti PR, Derr-Yellin EC, Casey AC, Kehn LS. PCBs, thyroid hormones, and ototoxicity in rats: cross-fostering experiments demonstrate the impact of postnatal lactation exposure. Toxicol Sci 2000; 57:131-140.
119. Juarez de Ku LM, Sharma-Stokkermans M, Meserve LA. Thyroxine normalizes poly-chlorinated biphenyl (PCB) dose-related depression of choline acetyltransferase (ChAT) activity in hippocampus and basal forebrain of 15-day-old rats. Toxicol 1994; 94:19-30.
120. Cooke PS, Zhao Y-D, Hansen LG. Neonatal polychlorinated biphenyl treatment increases adult testis size and sperm production in the rat. Toxicol Appl Pharmacol 1996; 136:112-117.
121. Baldridge MG, Stahl RL, Gerstenberger SL, Tripoli V, Hutz RJ. Modulation of ovarian follicle maturation in Long-Evans rats exposed to polychlorinated biphenyls (PCBs) in-utero and lactationally. Reprod Toxicol 2003; 17:567-573.
122. Goldey ES, Crofton KM. Thyroxine replacement attenuates hypothyroxinemia, hearing loss, and motor deficits following developmental exposure to Aroclor 1254 in rats. Toxicol Sci 1998; 45:94-105.
123. Connors JM, Hedge GA. Feedback regulation of thyrotropin by thyroxine under physiological conditions. Am J Physiol 1981; 240:E308-E313.
124. Schwartz HL. Effect of thyroid hormone on growth and development. In: Oppenheimer JH, Samuels HH, eds. Molecular Basis of Thyroid Hormone Action. New York: Academic Press, 1983:413-444.
125. Varma SK, Murray R, Stanbury JB. Effect of maternal hypothyroidism and triiodothyronine on the fetus and newborn in rats. Endocrinology 1978; 102:24-30.
126. Kolaja KL, Klaassen CD. Dose-response examination of UDP-glucuronosyltransferase inducers and their ability to increase both TGF-beta expression and thyroid follicular cell apoptosis. Toxicol Sci 1998; 46:31-37.
127. Hood A, Klaassen CD. Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues. Toxicol Appl Pharmacol 2000; 163:240-248.
128. Zoeller RT, Dowling AL, Vas AA. Developmental exposure to polychlorinated biphenyls exerts thyroid hormone-like effects on the expression of RC3/neurogranin and myelin basic protein messenger ribonucleic acids in the developing rat brain. Endocrinol 2000; 141:181-189.
129. McKinney JD, Waller CL. Polychlorinated biphenyls as hormonally active structural analogues. Environ Health Perspect 1994; 102:290-297.
130. Gauger KJ, Kato Y, Haraguchi K, et al. Polychlorinated biphenyls (PCBs) exert thyroid hormone-like effects in the fetal rat brain but do not bind to thyroid hormone receptors. Environ Health Perspect 2004; 112:516-523.
131. Song M-KH, Dozin B, Grieco D, Rall JE, Nikodem VM. Transcriptional activation and stabilization of malic enzyme mRNA precursor by thyroid hormone. J Biol Chem 1986; 263:17970-17974.
132. Cheek AO, Kow K, Chen J, McLachlan JA. Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. Environ Health Perspect 1999; 107:273-278.
133. Brouwer A, Morse DC, Lans MC, et al. Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol Ind Health 1998; 14:59-84.
134. Chauhan KR, Kodavanti PR, McKinney JD. Assessing the role of ortho-substitution on polychlorinated biphenyl binding to transthyretin, a thyroxine transport protein. Toxicol Appl Pharmacol 2000; 162:10-21.
135. Hood A, Klaassen CD. Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation. Toxicol Sci 2000; 55:78-84.
136. Liu J, Liu Y, Barter RA, Klaassen CD. Alteration of thyroid homeostasis by UDP-glucurono-syltransferase inducers in rats: a dose-response study. J Pharmacol Exp Ther 1995; 273:977-985.
137. Schneider MJ, Fiering SN, Pallud SE, Parlow AF. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 2001; 15:2137-2148.
138. Iwasaki T, Miyazaki W, Takeshita A, Kuroda Y, Koibuchi N. Polychlorinated biphenyls suppress thyroid hormone-induced transactivation. Biochem Biophys Res Commun 2002; 299:384-388.
139. Miyazaki W, Iwasaki T, Takeshita A, Kuroda Y, Koibuchi N. Polychlorinated biphenyls suppress thyroid hormone receptor-mediated transcription through a novel Mechanism. J Biol Chem 2004; 279:18195-18202.
140. Yamada-Okabe T, Aono T, Sakai H, Kashima Y, Yamada-Okabe H. 2,3,7,8-tetrachlor-odibenzo-p-dioxin augments the modulation of gene expression mediated by the thyroid hormone receptor. Toxicol Appl Pharmacol 2004; 194:201-210.